Leerink Partners is serving as exclusive financial advisor to Tectonic and Cooley LLP is serving as legal counsel to Tectonic. Leerink Partners and TD Cowen are...
AVROBIO’s Merger with Tectonic Therapeutic
Celadon Partners’ $38 Million Acquisition of Senti Bio’s Assets
Morrison Foerster advised Celadon Partners and GeneFab, while Cooley and Goodwin Procter advised Senti Biosciences. Senti Biosciences, Inc. (Nasdaq: SNTI) and Celadon Partners, LLC announced a transaction...
Angion’s Merger Agreement with Elicio Therapeutics
Cooley advised Angion on the deal. Angion, a clinical-stage biopharmaceutical company, announced its definitive merger agreement with Elicio Therapeutics. Elicio will merge with a wholly owned subsidiary...
Immatics’ License Agreement With Bristol Myers Squibb
Cooley LLP advised Immatics on the deal. Immatics, a clinical-stage biopharmaceutical company active in the discovery and development of T cell-redirecting cancer immunotherapies, announced its license, development...
Sunovion Pharmaceuticals’ Co-Development and Co-Commercialization Agreement with Otsuka Pharmaceutical
Ropes & Gray advised Sunovion Pharmaceuticals on the deal while Cooley represented Otsuka Pharmaceutical. Sunovion Pharmaceuticals Inc., a subsidiary of Japan’s Sumitomo Dainippon Pharma, signed a...